Literature DB >> 15635009

Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures.

Shiri Navon-Venezia1, Azita Leavitt, Ronen Ben-Ami, Yuval Aharoni, Mitchell J Schwaber, David Schwartz, Yehuda Carmeli.   

Abstract

We evaluated a protocol for the accelerated detection of extended-spectrum beta-lactamases (ESBLs) in gram-negative bloodstream pathogens. Two hundred eighty-three blood culture bottles were subjected to direct ESBL testing by inoculating samples directly from blood culture bottles onto agar plates containing cefotaxime and ceftazidime disks, with and without clavulanate. Standard ESBL testing in accordance with the NCCLS guidelines after subculturing on agar plates was performed in parallel. Results of the direct ESBL testing were reported 2.3 days sooner and were comparable to those of the standard NCCLS method with sensitivity, specificity, and positive and negative predictive values of 100, 98, 94, and 100%, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635009      PMCID: PMC540179          DOI: 10.1128/JCM.43.1.439-441.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns.

Authors:  G Saurina; J M Quale; V M Manikal; E Oydna; D Landman
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

2.  The importance of appropriate initial antibiotic therapy for hospital-acquired infections.

Authors:  Marin H Kollef
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

3.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.

Authors:  P L Winokur; R Canton; J M Casellas; N Legakis
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.

Authors:  M W Carter; K J Oakton; M Warner; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).

Authors:  Jan M Bell; John D Turnidge; Ana C Gales; Michael A Pfaller; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2002-03       Impact factor: 2.803

7.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Authors:  E Lautenbach; J B Patel; W B Bilker; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

8.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Authors:  Stephan Harbarth; Jorge Garbino; Jérome Pugin; Jacques A Romand; Daniel Lew; Didier Pittet
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

9.  Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures.

Authors:  S Navon-Venezia; R Ben-Ami; M J Schwaber; A Leavitt; D Schwartz; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-07       Impact factor: 3.267

10.  Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Patti M Raney; J Kamile Rasheed; James W Biddle; Portia Williams; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more
  1 in total

1.  Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.

Authors:  Deverick J Anderson; John J Engemann; Lizzie J Harrell; Yehuda Carmeli; L Barth Reller; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.